title: Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma.
abstract: BACKGROUND
  Osteosarcoma is an aggressive cancerous neoplasm arising from primitive transformed cells of mesenchymal origin that exhibit osteoblastic differentiation and produce malignant osteoid. With the rapid development of tumor molecular biology, gene and viral therapy, a highly promising strategy for the treatment, has shown some therapeutic effects.
  
  
  OBJECTIVE
  To study the strategy of cooperative cancer gene therapy, previously, we explored the antitumor effects of recombinant Fowl-pox viruses (FPVs) with both HN (hemagglutinin-neuramidinase) and VP3 genes on mouse osteosarcoma.
  
  
  METHODS
  We constructed vFV-HN, vFV-VP3 and vFV-HN-VP3 inserting CAV VP3 gene, NDV HN gene into fowlpox virus. S180 osteosarcoma were transfected with Recombinant Fowl-pox viruses (FPVs). These cell lines stably expressing tagged proteins were selected by culturing in medium containing puromycin (2 µg/ml) and confirmed by immunoblotting and immunostaining. S180 osteosarcoma model with BALB/c mice and nude mice were established and the vFPV viruses as control, vFV-HN, vFV-VP3, vFV-HN-VP3 were injected into the tumor directly. The rate of tumor growth, tumor suppression and the sialic acid levels in serum were examined and the tumor tissues were analyzed by the method of immunohistochemistry. Flow cytometric analysis was performed using a FACSCalibur flow cytometer. A total of 100,000 events were analyzed for each sample and the experiment was repeated at least twice.
  
  
  RESULTS
  Our data indicated that vFV-HN, vFV-VP3 and vFV-HN-VP3 all had growth inhibition effects, the inhibition rate of vFV-HN-VP3 group was 51.7%, which was higher than that of vFV-HN, vFV-VP3 group and control group (p < 0.01). The sialic acid level of vFV-HN-VP3 group in mouse serum was 4.22±0.27 mmol/l, which was lower than that of other groups (p < 0.01).
  
  
  CONCLUSIONS
  These results suggest that genes into mouse osteosarcoma cancer cells can cause cell a specificity anti-tumor immune activity, suppress tumor growth, and increase the survival rate of the tumor within host.
authors.affiliation: The 4th Affiliate Hospital of China Medical University, Shenyang, China. davidzhang77@sohu.com  
authors.forename: Z-Y
authors.initials: ZY
authors.lastname: Zhang
authors.forename: L-Q
authors.initials: LQ
authors.lastname: Wang
authors.forename: C-F
authors.initials: CF
authors.lastname: Fu
authors.forename: X
authors.initials: X
authors.lastname: Li
authors.forename: Z-L
authors.initials: ZL
authors.lastname: Cui
authors.forename: J-Y
authors.initials: JY
authors.lastname: Zhang
authors.forename: S-H
authors.initials: SH
authors.lastname: Xue
authors.forename: N
authors.initials: N
authors.lastname: Sun
authors.forename: F
authors.initials: F
authors.lastname: Xu
mesh_terms: D000818:Animals; D001859:Bone Neoplasms / Q000235:genetics / Q000628:therapy* / Q000821:virology; D036022:Capsid Proteins / Q000235:genetics*; D045744:Cell Line, Tumor; D005587:Fowlpox virus / Q000235:genetics*; D005814:Genes, Viral; D015316:Genetic Therapy / Q000379:methods*; D015707:HN Protein / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D050130:Oncolytic Virotherapy / Q000379:methods*; D012516:Osteosarcoma / Q000235:genetics / Q000628:therapy* / Q000821:virology; D014162:Transfection
chemical_list: D036022:Capsid Proteins; D015707:HN Protein